These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2998254
1. S-2-(3-Aminopropylamino)ethyl phosphorothioic acid (WR-2721) in primary hyperparathyroidism. Morita M, Higashi K, Tajiri J, Sato T. Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):961. PubMed ID: 2998254 [No Abstract] [Full Text] [Related]
2. Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid. Glover DJ, Shaw L, Glick JH, Slatopolsky E, Weiler C, Attie M, Goldfarb S. Ann Intern Med; 1985 Jul; 103(1):55-7. PubMed ID: 2988391 [Abstract] [Full Text] [Related]
3. Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient. Zingraff J, Bourdeau A, Clair F, Kindermans C, Buisson C, Manganella G, Sachs C, Drüeke T. Nephrol Dial Transplant; 1987 Jul; 2(1):48-52. PubMed ID: 3037448 [Abstract] [Full Text] [Related]
4. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma. Hirschel-Scholz S, Jung A, Fischer JA, Trechsel U, Bonjour JP. Clin Endocrinol (Oxf); 1985 Sep; 23(3):313-8. PubMed ID: 3000652 [Abstract] [Full Text] [Related]
5. Effect of S-2(3-aminopropylamino) ethyl phosphorothioic acid on ATPase activity in the testis of irradiated mouse. Jaimala, Bhartiya HC. Radiobiol Radiother (Berl); 1986 Sep; 27(4):485-9. PubMed ID: 3022328 [No Abstract] [Full Text] [Related]
6. Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism. Hirschel-Scholz S, Caverzasio J, Bonjour JP. Adv Exp Med Biol; 1986 Sep; 208():367-70. PubMed ID: 3031946 [No Abstract] [Full Text] [Related]
7. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent. Hirschel-Scholz S, Caverzasio J, Bonjour JP. J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292 [Abstract] [Full Text] [Related]